{"id":523,"date":"2023-10-04T19:33:48","date_gmt":"2023-10-04T19:33:48","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=523"},"modified":"2023-10-11T19:35:24","modified_gmt":"2023-10-11T19:35:24","slug":"bevigilant-orafusion-system-released-in-italy","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/de\/bevigilant-orafusion-system-in-italien-veroffentlicht\/","title":{"rendered":"BeVigilant\u2122 OraFusion\u2122 System in Italien ver\u00f6ffentlicht"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201c1\u2033 _builder_version=\u201c4.16\u2033 lock=\u201coff\u201c global_colors_info=\u201c{}\u201c][et_pb_row _builder_version=\u201c4.16\u2033 background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c global_colors_info=\u201c{ }\u201c][et_pb_column type=\u201c4_4\u2033 _builder_version=\u201c4.16\u2033 custom_padding=\u201c|||\u201c global_colors_info=\u201c{}\u201c custom_padding__hover=\u201c|||\u201c][et_pb_text _builder_version=\u201c4.22.2\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding =\u201c25px||||false|false\u201c global_colors_info=\u201c{}\u201c]<\/p>\n<h2>Vigilant Biosciences\u00ae ist f\u00fchrend im Kampf gegen Mundkrebs<\/h2>\n<p>Lakeway, Texas (4. Oktober 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201eVigilant\u201c), ein branchenf\u00fchrender Entwickler hochmoderner L\u00f6sungen, die die Erkennung von Mundkrebs beschleunigen, gibt die Ver\u00f6ffentlichung seines Flaggschiffprodukts BeVigilant\u2122 bekannt OraFusion\u2122 System, in Italien. <\/p>\n<p>Das BeVigilant\u2122 OraFusion\u2122 System ist ein bahnbrechendes Ger\u00e4t, das eine Risikobewertung von Mundkrebs direkt am Behandlungsort durchf\u00fchrt. Das System liefert ein genaues Risikobewertungsergebnis durch die kombinierte Analyse von Biomarkerkonzentrationen im Fr\u00fchstadium und eine intelligente softwaregest\u00fctzte Bewertung klinischer Risikofaktoren. Diese integrierte Analyse stellt \u00c4rzten an vorderster Front die notwendigen Daten zur Verf\u00fcgung, um fundierte Behandlungsentscheidungen f\u00fcr Patienten mit oralen L\u00e4sionen zu treffen.<\/p>\n<p>\u201eVgilant hat sich von Anfang an zum Ziel gesetzt, die \u00dcberlebensrate von Mundkrebs durch Fr\u00fcherkennung und Intervention zu erh\u00f6hen\u201c, sagte Bill Brodie, CEO von Vigilant Biosciences\u00ae. \u201eDas BeVigilant\u2122 OraFusion\u2122 System tr\u00e4gt dieses Ziel zum Erfolg bei und hilft \u00c4rzten bei der Beurteilung von Mundkrebs, diesen fr\u00fcher als je zuvor zu erkennen.\u201c Wir glauben, dass unsere Technologie den von dieser Krankheit Betroffenen Hoffnung und lebensrettende Ergebnisse bringen wird, indem wir den n\u00e4chsten Schritt bei der Neugestaltung der Erkennung von Mundkrebs unternehmen.\u201c<\/p>\n<p>Wenn Patienten im Fr\u00fchstadium von Mundkrebs an eine spezialisierte Behandlung \u00fcberwiesen werden, ist die Behandlung oft weniger invasiv und effektiver, was zu deutlich besseren Ergebnissen f\u00fchrt. Die aktuelle \u00dcberlebensrate bei Mundkrebs liegt bei 50%, aber eine fr\u00fchzeitige Erkennung kann die \u00dcberlebensrate erheblich auf bis zu 90% erh\u00f6hen. <\/p>\n<p>Vigilant Biosciences\u00ae ist weiterhin Vorreiter im Kampf gegen Mundkrebs mit einfachen, genauen und kosteng\u00fcnstigen L\u00f6sungen, die eine Fr\u00fcherkennung, wirksame Intervention und bessere Ergebnisse erm\u00f6glichen. Weitere Informationen zu Vigilant Biosciences\u00ae und seinen Produkten finden Sie unter <a href=\"https:\/\/vigilantbiosciences.com\/de\/\">https:\/\/vigilantbiosciences.com\/<\/a>. <\/p>\n<p>Hinweis: Das BeVigilant\u2122 OraFusion\u2122 System ist in den USA nicht zum Verkauf erh\u00e4ltlich<\/p>\n<p><strong>\u00dcber Vigilant Biosciences\u00ae, Inc.<\/strong><br \/>\nVigilant Biosciences\u00ae ist ein f\u00fchrender Innovator und Entwickler von L\u00f6sungen, die \u00c4rzte bei der Fr\u00fcherkennung von Mundkrebs unterst\u00fctzen. Die BeVigilant\u2122-Produktlinie von Vigilant umfasst Point-of-Care-Tests, die einfach, genau und kosteng\u00fcnstig sind und es \u00c4rzten erm\u00f6glichen, das Leben durch fr\u00fchere Interventionen zu verbessern. Erfahren Sie mehr \u00fcber Vigilant Biosciences\u00ae unter <a href=\"https:\/\/vigilantbiosciences.com\/de\/\">https:\/\/vigilantbiosciences.com\/<\/a>.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Vigilant Biosciences\u00ae f\u00fchrt den Kampf gegen Mundkrebs an Lakeway, Texas (4. Oktober 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201eVigilant\u201c), ein branchenf\u00fchrender Entwickler innovativer L\u00f6sungen, die die Erkennung von Mundkrebs beschleunigen, k\u00fcndigt die Ver\u00f6ffentlichung seines Flaggschiffprodukts, des BeVigilant\u2122 OraFusion\u2122 Systems, in Italien an. Das BeVigilant\u2122 OraFusion\u2122 System ist ein bahnbrechendes Ger\u00e4t, das eine [\u2026]<\/p>","protected":false},"author":3,"featured_media":527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/de\/bevigilant-orafusion-system-in-italien-veroffentlicht\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/de\/bevigilant-orafusion-system-in-italien-veroffentlicht\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-04T19:33:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T19:35:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\",\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"description\":\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/de\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/de\/bevigilant-orafusion-system-in-italien-veroffentlicht\/","og_locale":"de_DE","og_type":"article","og_title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","og_description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","og_url":"https:\/\/vigilantbiosciences.com\/de\/bevigilant-orafusion-system-in-italien-veroffentlicht\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-04T19:33:48+00:00","article_modified_time":"2023-10-11T19:35:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"dex.manley","Gesch\u00e4tzte Lesezeit":"2 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy","datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"wordCount":431,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","url":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/de\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media\/527"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/tags?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}